Astal Laboratories Limited (BOM:512600)

Market Cap	3.26B +307.3%
Revenue (ttm)	1.37B +161.0%
Net Income	97.74M +51.8%
EPS	7.22 +3.7%
Shares Out	42.22M
PE Ratio	10.69
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,710
Average Volume	11,936
Open	75.98
Previous Close	71.56
Day's Range	72.06 - 78.00
52-Week Range	70.10 - 103.20
Beta	-0.84
RSI	48.16
Earnings Date	Feb 9, 2026

About Astal Laboratories

Astal Laboratories Limited manufactures and sells pharmaceutical intermediates and bulk drugs in India. The company was formerly known as Macro International Limited and changed its name to Astal Laboratories Limited in April 2024. Astal Laboratories Limited was incorporated in 1993 and is headquartered in Jaipur, India. Astal Laboratories Limited operates as a subsidiary of Aceso Research Labs LLP.

• Industry: Short-Term Business Credit Institutions, Except Agricultural
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 512600

Financial Performance

In fiscal year 2025, Astal Laboratories's revenue was 636.55 million, an increase of 169.15% compared to the previous year's 236.50 million. Earnings were 89.25 million, an increase of 1037.42%.